Large-scale testing (Phase 3)Ended earlyNCT00055198
What this trial is testing
Daptomycin for the Treatment of Infections Due to Gram-Positive Bacteria
Who this might be right for
Gram-Positive Bacterial Infections
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 75